FormDSignal
52

OS Therapies raises $12.28M in biotech offering under Reg D 506(b)

Company raise · Raising · GRASONVILLE, MD · Form D filed 2026-10-23

OS Therapies Inc, a Delaware biotech corporation based in Grasonville, Maryland, is raising $12.28M and has sold $7.17M to 9 investors as of October 15, 2026. The offering is being conducted under Regulation D exemption 506(b) with Ceros Financial Services as placement agent.

$10M+ raisePlacement agent engagedoperating_company

Why now — by persona

  • Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock

People on the filing

Paul A. RomnessChairman, President and Chief Executive Officer
Robert G. PetitChief Medical Officer and Chief Scientific Officer
Francis Knuettel IIChief Financial Officer
John CiccioDirector
Avril McKean DieserDirector
Craig EagleDirector
Olivier JarryDirector
Theodore F. SearchDirector
Kerry ClemChief Commercial Officer

Signed by Francis Knuettel II, Chief Financial Officer.

Placement agents / sales compensation: Ceros Financial Services, Inc.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.

Other filings by this issuer